世界中医药
文章摘要
引用本文:黄晓华1,尹天雷2,李鹤白3.芪连片治疗慢性非特异性溃疡性结肠炎临床研究[J].世界中医药,2015,10(08):.  
芪连片治疗慢性非特异性溃疡性结肠炎临床研究
Clinical Research of Qilian Tablets in Treating Chronic Non-specific Ulcerative Colitis
投稿时间:2015-05-12  
DOI:10.3969/j.issn.1673-7202.2015.08.013
中文关键词:  慢性非特异性溃疡性结肠炎  芪连片
English Keywords:Chronic non-specific ulcerative colitis  Qilian tablets
基金项目:湖南省科技厅基金项目(编号:2009WK3061)
作者单位
黄晓华1,尹天雷2,李鹤白3 1 黑龙江省佳木斯市中心医院中医科,佳木斯,154002
2 湖南省中医药研究院附属医院重点专科办公室,长沙,410006
3 世界中医药学会联合会国际培训部,北京,100101 
摘要点击次数: 1133
全文下载次数: 1169
中文摘要:
      目的:探讨自拟芪连片治疗慢性非特异性溃疡性结肠炎的临床疗效及安全性。方法:将143例中医符合脾胃气虚及湿热内蕴证候的慢性非特异性溃疡性结肠炎患者按3:1随机分为治疗108例和对照组35例。治疗组采用芪连片和模拟补脾益肠丸治疗,对照组采用模拟芪连片和补脾益肠丸进行治疗。疗程2个月。结果:治疗组慢性非特异性溃疡性结肠炎疾病疗效评价的显效率为27.78%,总有效率85.19%,对照组分别为22.86%和77.14%;治疗组中医证候(湿热内蕴)总显效率为72.22%,总有效率94.44%,对照组分别为51.43%和88.57%,组间比较差异有统计学意义(P<0.05)。结论:采用芪连片治疗性非特异性溃疡性结肠炎疗效满意。
English Summary:
      To explore and discuss the clinical efficacy and safety of the self-designed prescription, Qilian tablets, in treating chronic non-specific ulcerative colitis. Methods: A total of 143 patients with chronic non-specific ulcerative colitis, who are categorized under traditional Chinese medical theory as spleen-stomach qi deficiency and internal accumulation of dampness-heat were randomly divided into a treatment group(108 cases)and a control group(35 cases)at a ratio of 3:1. Treatment group had Qilian tablets and a prescription mimicking spleen and intestine invigorating pills. Control group utilized a prescription mocking the efficacy of Qilian tablets and a combination of spleen and intestine invigorating pills. Two groups received treatment for two months. Results: In the treatment group, while treating chronic non-specific ulcerative colitis, the treatment efficacy was listed with an obvious effective rate of 27.78%, a total effective rate of 85.19%. In the control group, the rate was 22.86% and 77.14% respectively. Among the treatment group under the internal accumulation of dampness-heat subcategory, the total obvious effective rate was 72.22%, the total effective rate was 94.44%; while the rate at the control group was at 51.43% and 88.57% accordingly. Comparison among groups presented with a difference which has statistical significance(P<0.05). Conclusion: Utilizing Qilian tablets in treating chronic non-specific ulcerative colitis showed satisfactory efficacy.
查看全文  查看/发表评论  下载PDF阅读器